Researchers Matthijs van Luin

Matthijs van Luin

Research Staff Other

Contact

Recent publications

Impact of generic antiretroviral drugs introduction on pharmaceutical expenditure patterns in the Netherlands P Oosterhof, M Van Luin, J W Vanhommerig, K Brinkman, D M Burger
BMC Health Services Research, 2025, vol. 25

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis Anne M Akkerman-Nijland, Paul Hagedoorn, Bart L Rottier, Floris Grasmeijer, Henderik Erik W Frijlink, Mathijs van Luin, E Ter Weijden, Peter J Merkus, Daan J Touw, Onno W Akkerman, Gerard H Koppelman
Pharmaceutics, 2025, vol. 17

ADMETTRE MTX-studie Julia E. Möhlmann, Sytze de Roock, Annelies C. Egas, Evelien ter Weijden, Martijn J.H. Doeleman, Alwin D.R. Huitema, Joost F. Swart, Matthijs van Luin
Pharmaceutisch Weekblad, 2024, vol. 159, p.28-33

Bioanalysis of protein-unbound prednisolone in serum using equilibrium dialysis followed by liquid chromatography-tandem mass spectrometry J E Möhlmann, M van Luin, E G W M Lentjes, A D R Huitema, A M Punt
Journal of Chromatography B, 2024, vol. 1252

Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases Julia E. Möhlmann, Solaiman Ezzafzafi, Caroline A. Lindemans, Marc H.A. Jansen, Stefan Nierkens, Alwin D.R. Huitema, Matthijs van Luin
Clinical Pharmacokinetics, 2024, vol. 63, p.1251-1270

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study Renske van der Meer, Erik B Wilms, Margot N Eggermont, Helena M Paalvast, Matthijs van Luin, Richard C J M van Rossen, Harry G M Heijerman
Journal of Cystic Fibrosis, 2024, vol. 23, p.549-553

External positions

ISO15189 auditor voor TDM / Toxicologie Laboratoria - Het TDM Lab van het UMCU is ISO 15189 geaccrediteerd, veel raakvlak dus met TDM apotheker functie - Raad voor Accreditatie